New perspectives in the treatment of Parkinson's disease.
D001971:Bromocriptine / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D011954:Receptors, Dopamine / Q000187:drug effects; D012642:Selegiline / Q000627:therapeutic use; D012844:Sincalide / Q000627:therapeutic use
D011954:Receptors, Dopamine; D012642:Selegiline; D001971:Bromocriptine; D007980:Levodopa; D012844:Sincalide; D004298:Dopamine